RUTH MATTHEW R. (Chief Commercial Officer) sold 3.5% of their position (1.08K shares) of OPIANT PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $11.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/21/2022ACC: 0001385508-22-000114
Officer· Chief Commercial Officer
Since Jul 2021
-1.08K
Net shares
Net seller
$11.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.08K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.08K
Price / share
$10.62
Trade value
$11.51K
% of position
3.5%
7/20/2022
31K→29.92K
Total
Net shares
−1.08K
Net value
-$11.51K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/20/2022 | S · Sale | −1.08K | $10.62 | $11.51K | 3.5% | 31K | 29.92K |
| Total | −1.08K | -$11.51K | ||||||
Derivative Transactions0
No derivative transactions reported